Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer Medicine|May 4, 2018
Prognostic relevance and performance characteristics of serum IGFBP-2 and PAPP-A in women with breast cancer: a long-term Danish cohort studyUlrick Espelund, Andrew G Renehan, Søren Cold, et al.
Frontiers in Endocrinology|September 28, 2020
Pregnancy-Associated Plasma Protein-A2 Is Associated With Mortality in Patients With Lung CancerRikke Hjortebjerg, Ulrick Espelund, Torben Riis Rasmussen, et al.
Clinical Endocrinology|September 23, 2009
Ascites from patients with alcoholic liver cirrhosis contains higher IGF-I bioactivity than serumNilani Jeyaratnaganthan, Henning Grønbaek, Peter Holland-Fischer, et al.
European Journal of Endocrinology|November 2, 2013
Serum levels of bioactive IGF1 and physiological markers of ageing in healthy adultsPoul Frølund Vestergaard, Mette Hansen, Jan Frystyk, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|June 13, 2015
The Circulating IGF System in Hepatocellular Carcinoma: The Impact of Liver Status and TreatmentUlrick Espelund, Henning Grønbæk, Gerda Elisabeth Villadsen, et al.
Scandinavian Journal of Gastroenterology|June 25, 2014
Vitamin B₁₂ and its binding proteins in hepatocellular carcinoma and chronic liver diseasesKira Simonsen, Anthony Rode, Amanda Nicoll, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2004
Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: studies in obese and normal-weight subjectsUlrick Espelund, Troels Krarup Hansen, Kurt Højlund, et al.
Oncotarget|September 5, 2015
PAPP-A proteolytic activity enhances IGF bioactivity in ascites from women with ovarian carcinomaJacob Thomsen, Rikke Hjortebjerg, Ulrick Espelund, et al.
Pageof 2